MedTrace Logo

Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma

NCT04648163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2020-12-01

No results posted yet for this study

Summary

Postoperative complications like seroma formation and wound site infection readily occur following completion axillary lymph node dissection (ALND) for malignant melanoma. We analyzed the impact of time-to-drain removal and drainage volume on seroma formation after ALND.

Conditions

  • Malignant Melanoma

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • David B Lumenta, MD, Prof · Medical University of Graz

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-05-01
Completion
2018-09-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04648163 on ClinicalTrials.gov